Literature DB >> 17016440

STAT1-independent inhibition of cyclooxygenase-2 expression by IFNgamma; a common pathway of IFNgamma-mediated gene repression but not gene activation.

L Klampfer1, J Huang, P Kaler, T Sasazuki, S Shirasawa, L Augenlicht.   

Abstract

Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in the synthesis of prostaglandins, promotes the development of colorectal cancer, and is a key molecular target of non-steroidal anti-inflammatory drugs, compounds that reduce the relative risk of developing colon cancer. In this study, we showed that interferon gamma (IFNgamma) inhibits the expression of COX-2 protein in intestinal epithelial cells (IECs) through a pathway that requires Janus-activated kinase (JAK) activity. In contrast, we demonstrated that transcriptional inhibition of COX-2 by IFNbeta or IFNgamma occurs in cells with silenced signal transducer and activator of transcription 1 (STAT1) expression and that IFNs retained the ability to inhibit COX-2 transcription in cells with activated RasV12, in which IFNgamma failed to induce STAT1. Thus, unlike the activity of JAK, STAT1 is not required for the inhibition of COX-2 expression by IFNgamma. In contrast to COX-2, the activation of genes in response to IFNgamma, such as interferon regulatory factor-1, was severely impaired by both STAT1 silencing and by constitutive Ras signaling. To determine whether there is a general differential requirement for STAT1 in gene activation and gene repression in response to IFNgamma in intestinal cells, we performed genome-wide analysis of IFNgamma target genes in an IEC line in which STAT1 expression was silenced by small interfering RNA. The results confirmed that the activation of the majority of genes by IFNgamma required STAT1. In contrast, the repression of several genes, as we showed for COX-2 specifically, was largely unaffected in cells with silenced STAT1. Our results therefore demonstrate that in general gene activation by IFNgamma is more sensitive to STAT1 deficiency than gene repression, and suggest that IFNgamma activates and represses gene expression via distinct pathways that can be distinguished, at least in part, by their requirement for STAT1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016440     DOI: 10.1038/sj.onc.1210015

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  IFN-γ attenuates hypoxia-inducible factor (HIF) activity in intestinal epithelial cells through transcriptional repression of HIF-1β.

Authors:  Louise E Glover; Karina Irizarry; Melanie Scully; Eric L Campbell; Brittelle E Bowers; Carol M Aherne; Douglas J Kominsky; Christopher F MacManus; Sean P Colgan
Journal:  J Immunol       Date:  2011-01-03       Impact factor: 5.422

Review 2.  Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.

Authors:  John W Steinke; Spencer C Payne; Larry Borish
Journal:  Immunol Allergy Clin North Am       Date:  2016-09-13       Impact factor: 3.479

3.  Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG.

Authors:  Xindong Liu; Lilin Ye; Yu Bai; Habi Mojidi; Neil E Simister; Xiaoping Zhu
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

4.  Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.

Authors:  Ricardo Valladares; Dhyana Sankar; Nan Li; Emily Williams; Kin-Kwan Lai; Asmaa Sayed Abdelgeliel; Claudio F Gonzalez; Clive H Wasserfall; Joseph Larkin; Desmond Schatz; Mark A Atkinson; Eric W Triplett; Josef Neu; Graciela L Lorca
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

5.  IFN-gamma regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells.

Authors:  Zhila Khalkhali-Ellis; Daniel E Abbott; Caleb M Bailey; William Goossens; Naira V Margaryan; Stephen L Gluck; Moshe Reuveni; Mary J C Hendrix
Journal:  J Cell Biochem       Date:  2008-09-01       Impact factor: 4.429

6.  Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes.

Authors:  Hyeonjoo Cheon; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

7.  Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses.

Authors:  Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone
Journal:  JAKSTAT       Date:  2016-05-18

8.  Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis.

Authors:  Mirko Trilling; Nicolás Bellora; Andrzej J Rutkowski; Miranda de Graaf; Paul Dickinson; Kevin Robertson; Olivia Prazeres da Costa; Peter Ghazal; Caroline C Friedel; M Mar Albà; Lars Dölken
Journal:  Nucleic Acids Res       Date:  2013-07-05       Impact factor: 16.971

9.  The Role of STAT1 for Crosstalk between Fibroblasts and Colon Cancer Cells.

Authors:  Pawan Kaler; Benjamin Y Owusu; Leonard Augenlicht; Lidija Klampfer
Journal:  Front Oncol       Date:  2014-04-30       Impact factor: 6.244

10.  The Inflammatory Transcription Factors NFκB, STAT1 and STAT3 Drive Age-Associated Transcriptional Changes in the Human Kidney.

Authors:  Zach K O'Brown; Eric L Van Nostrand; John P Higgins; Stuart K Kim
Journal:  PLoS Genet       Date:  2015-12-17       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.